Structure-Activity Relationships and Drug Design
Ligand Binding Sites
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
Quantitative Aspects of Drug-Receptor Interaction
The Equilibrium Binding Constant and Binding Strength
Conserved Binding Sites
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 7, 2025

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
Zhongyu Wang1, Jingwen Chen1, Huixiao Hong2
1Key Laboratory of Industrial Ecology and Environmental Engineering (Ministry of Education), Dalian Key Laboratory on Chemicals Risk Control and Pollution Prevention Technology, School of Environmental Science and Technology, Dalian University of Technology, Dalian 116024, China.
Developing quantitative structure-activity relationship (QSAR) models for peroxisome proliferator-activated receptor gamma (PPARγ) binding is crucial for identifying endocrine disruptors. This study introduces novel applicability domains (ADs) and structure-activity landscape (SAL) analyses to improve QSAR model reliability.
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
06:50Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
Published on: January 26, 2024
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: